Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion type Assertion NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_head.
- NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion description "[Analysis of the individual phenotypes (RA or JIA) showed that both the IL-4 +33 TT (P = 0.02; OR: 0.25, 95% CI: 0.07-0.87) and the IL-4R Q551R CC genotypes (P = 0.001; OR: 0.19, 95% CI: 0.06-0.56) were exclusively decreased in female RA patients compared to female controls.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_provenance.
- NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion evidence source_evidence_literature NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_provenance.
- NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion SIO_000772 16551465 NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_provenance.
- NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion wasDerivedFrom gad-20150221 NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_provenance.
- NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_assertion wasGeneratedBy ECO_0000203 NP71100.RAs008A6Y2mUrxq5fHldUsMoA5E2PB-G8PjUvPf7t21kA130_provenance.